![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEgbTQdYOjVcYC43yJHHgEaq-y8kyWWeUy765cVgbhStyIOfFd4s4xp3iCtweT_CQr5ZWDP8YV1fE-lDWSqbFySaG4Kb5SB6CVyC1zYLmAq4R1flUIKbbm-p3iowIP45TOcjwWNEudp9gbo_/s1600/ipos-lrg+%25281%2529.jpg)
Also pricing:
- Genfit SA (GNFT) on March 26.
- Precision Biosciences (DTIL) and 8I Enterprises Aquisition Corp. (JFKKU) on March 27.
IPO lockup expirations:
- Arco Platform (NASDAQ:ARCE), Capital Bancorp (NASDAQ:CBNK), Entasis Therapeutics Holdings (NASDAQ:ETTX), SVMK (NASDAQ:SVMK), and Viomi Technology (NASDAQ:VIOT) on March 25.
- Arvinas (NASDAQ:ARVN), Laix (NYSE:LAIX), RA Medical Systems (NYSE:RMED), Sutro Biopharma (NASDAQ:STRO) and Urovant Sciences (NASDAQ:UROV) on March 26.
- CooTek Cayman (NYSE:CTK) and Gritstone Oncology (NASDAQ:GRTS) on March 27.
IPO quiet period expirations:
- Kaleido Biosciences (NASDAQ:KLDO), Anchiano Therapeutics (NASDAQ:ANCN) and Imac Holdings (NASDAQ:IMAC) on March 25.
- Avedro (NASDAQ:AVDR) and TCR2 Therapeutics (NASDAQ:TCRR) on March 26.
- Hoth Therapeutics (NASDAQ:HOTH) and Stealth Biotherapeutics (NASDAQ:MITO) on March 27.
No comments:
Post a Comment